197 related articles for article (PubMed ID: 3390837)
1. Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Murray JL; Lamki LM; Shanken LJ; Blake ME; Plager CE; Benjamin RS; Schweighardt S; Unger MW; Rosenblum MG
Cancer Res; 1988 Aug; 48(15):4417-22. PubMed ID: 3390837
[TBL] [Abstract][Full Text] [Related]
2. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Murray JL; Rosenblum MG; Lamki L; Glenn HJ; Krizan Z; Hersh EM; Plager CE; Bartholomew RM; Unger MW; Carlo DJ
J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
Murray JL; Rosenblum MG; Lamki L; Haynie TP; Glenn HJ; Plager CE; Unger MW; Carlo DJ; Hersh EM
NCI Monogr; 1987; (3):3-9. PubMed ID: 3821916
[TBL] [Abstract][Full Text] [Related]
5. Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibody.
Buchsbaum DJ; Wahl RL; Glenn SD; Normolle DP; Kaminski MS
Cancer Res; 1992 Feb; 52(3):637-42. PubMed ID: 1732052
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
7. Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibody.
Carrasquillo JA; Abrams PG; Schroff RW; Reynolds JC; Woodhouse CS; Morgan AC; Keenan AM; Foon KA; Perentesis P; Marshall S
J Nucl Med; 1988 Jan; 29(1):39-47. PubMed ID: 3335926
[TBL] [Abstract][Full Text] [Related]
8. Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111indium labelled (MoAb).
Lamki LM; Murray JL; Rosenblum MG; Patt YZ; Babaian R; Unger MW
Nucl Med Commun; 1988 Aug; 9(8):553-64. PubMed ID: 3173914
[TBL] [Abstract][Full Text] [Related]
9. Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans.
Eger RR; Covell DG; Carrasquillo JA; Abrams PG; Foon KA; Reynolds JC; Schroff RW; Morgan AC; Larson SM; Weinstein JN
Cancer Res; 1987 Jun; 47(12):3328-36. PubMed ID: 3581071
[TBL] [Abstract][Full Text] [Related]
10. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
Lamki LM; Zukiwski AA; Shanken LJ; Legha SS; Benjamin RS; Plager CE; Salk DF; Schroff RW; Murray JL
Cancer Res; 1990 Feb; 50(3 Suppl):904s-908s. PubMed ID: 2297740
[TBL] [Abstract][Full Text] [Related]
11. Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer.
Patt YZ; Lamki LM; Haynie TP; Unger MW; Rosenblum MG; Shirkhoda A; Murray JL
J Clin Oncol; 1988 Aug; 6(8):1220-30. PubMed ID: 3045263
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Murray JL; Rosenblum MG; Sobol RE; Bartholomew RM; Plager CE; Haynie TP; Jahns MF; Glenn HJ; Lamki L; Benjamin RS
Cancer Res; 1985 May; 45(5):2376-81. PubMed ID: 3986779
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody.
Taylor A; Milton W; Eyre HP; Christian P; Wu F; Hagan P; Alazraki N; Datz FL; Unger M
J Nucl Med; 1988 Mar; 29(3):329-37. PubMed ID: 3346743
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
[TBL] [Abstract][Full Text] [Related]
15. [Radioimmunoimaging of malignant melanoma with In-111 labeled monoclonal antibody 96.5 and ZME-0.18].
Ishii K; Nishiyama S; Oyamada H; Endo K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1194-203. PubMed ID: 2730019
[TBL] [Abstract][Full Text] [Related]
16. Scintigraphic detection of metastatic melanoma using indium 111/DTPA conjugated anti-gp240 antibody (ZME-018).
Kirkwood JM; Neumann RD; Zoghbi SS; Ernstoff MS; Cornelius EA; Shaw C; Ziyadeh T; Fine JA; Unger MW
J Clin Oncol; 1987 Aug; 5(8):1247-55. PubMed ID: 3625247
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical pharmacology of [111In]-labeled murine monoclonal antibodies.
Rosenblum MG; Murray JL; Lamki L; David G; Carlo D
Cancer Chemother Pharmacol; 1987; 20(1):41-7. PubMed ID: 3621452
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced changes in pharmacokinetics and tumor uptake of 111In-labeled antimelanoma antibody 96.5 in melanoma patients.
Rosenblum MG; Lamki LM; Murray JL; Carlo DJ; Gutterman JU
J Natl Cancer Inst; 1988 Apr; 80(3):160-5. PubMed ID: 3346909
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.
Halpern SE; Dillman RO; Witztum KF; Shega JF; Hagan PL; Burrows WM; Dillman JB; Clutter ML; Sobol RE; Frincke JM
Radiology; 1985 May; 155(2):493-9. PubMed ID: 3983401
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs.
Berry CR; Fisher P; Koblik PD; Guilford WG; Hornof WH
Am J Vet Res; 1997 Nov; 58(11):1188-92. PubMed ID: 9361875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
